t********t
发帖数: 18 | 1 大家好！请问在美国，非小细胞肺癌四期，有什么有效的靶向治疗或者免疫治疗方法么
？非常感谢！ |
e******e
发帖数: 118 | 2 immunotherapy such as nivolumab or pembrolizumab usually is not used as
frontline treatment for stage IV nonsmall cell lung cancer, but can be
considered as 2nd line/3r line treatment option. response rate ~20% and
overall survival benefit is about 3 months. |
t********t
发帖数: 18 | 3 大家好！请问在美国，非小细胞肺癌四期，有什么有效的靶向治疗或者免疫治疗方法么
？非常感谢！ |
e******e
发帖数: 118 | 4 immunotherapy such as nivolumab or pembrolizumab usually is not used as
frontline treatment for stage IV nonsmall cell lung cancer, but can be
considered as 2nd line/3r line treatment option. response rate ~20% and
overall survival benefit is about 3 months. |
w*l
发帖数: 43 | 5 Update: NSCLC, advanced, 如果有至少50%细胞表达PD-L1， 可以用Pembrolizumab 作
为一线药。 效果比platinum药物好些，副作用少些。
Ref： Martin Reck， et al., Pembrolizumab versus Chemotherapy for PD-L1–
Positive Non–Small-Cell Lung Cance. NEJM, 2016, 375(19): 1823-1833. |
